SpaceX’s 32nd resupply mission for NASA includes ISS National Lab-sponsored biomedical research, physical sciences projects, technology demonstrations, and NSF-funded science
KENNEDY SPACE CENTER, Fla., April 18, 2025 /PRNewswire/ — A project to manufacture nanomaterials that could provide new treatments for osteoarthritis and cancer joins a trio of investigations funded by the U.S. National Science Foundation (NSF) and more on SpaceX’s 32nd Commercial Resupply Services (CRS) mission for NASA to the International Space Station (ISS). These investigations, sponsored by the ISS National Laboratory®, aim to benefit humanity and foster a robust economy in low Earth orbit (LEO).
This mission is scheduled to launch no earlier than April 21, 2025, at 4:15 a.m. EDT, from Launch Complex 39A at NASA’s Kennedy Space Center in Florida. Below are highlights of ISS National Lab-sponsored investigations on this mission.
For more information on ISS National Lab-sponsored investigations on this mission, visit our launch page. To learn more about the research and technology development sponsored by the ISS National Lab, including how to propose concepts for future space-based research, visit our website.
Download a high-resolution image for this release: SpaceX Falcon 9 Rocket
About the International Space Station (ISS) National Laboratory:
The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space® (CASIS®) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.
As a 501(c)(3) nonprofit organization, CASIS accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.
Media Contact: |
Patrick O’Neill |
904-806-0035 |
|
International Space Station (ISS) National Laboratory |
1005 Viera Blvd., Suite 101, Rockledge, FL 32955 • 321.253.5101 • www.ISSNationalLab.org |
SOURCE International Space Station National Lab
Winter Park, Florida--(Newsfile Corp. - May 5, 2025) - Adia Nutrition, Inc. (OTC Pink: ADIA),…
Ontada researchers to present 14 data presentations at ISPOR 2025 including a podium presentation on…
Board expansion reflects Company’s commitment to leadership and innovation in remote cardiac monitoring SANTA CLARA,…
DiaSafe™, IR-MED's second product, is being developed to provide safe, real-time optical readings of biomarkers…
Financial results to be released before market open; Conference call to be conducted at 9:00…
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of…